{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:32:09Z","timestamp":1777433529927,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bbalip.2022.159182","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T02:33:47Z","timestamp":1653014027000},"page":"159182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Protein-based HDL subspecies: Rationale and association with cardiovascular disease, diabetes, stroke, and dementia"],"prefix":"10.1016","volume":"1867","author":[{"given":"F.M.","family":"Sacks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.bbalip.2022.159182_bb0005","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Angelantonio","year":"2009","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.bbalip.2022.159182_bb0010","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.bbalip.2022.159182_bb0015","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.bbalip.2022.159182_bb0020","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Group","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbalip.2022.159182_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.bbalip.2022.159182_bb0030","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Investigators","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2022.159182_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2017.04.008","article-title":"Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: the ACCENTUATE trial","volume":"261","author":"Nicholls","year":"2017","journal-title":"Atherosclerosis"},{"issue":"9841","key":"10.1016\/j.bbalip.2022.159182_bb0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0045","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of lipid fractions with risks for coronary artery disease and diabetes","volume":"1","author":"White","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"11","key":"10.1016\/j.bbalip.2022.159182_bb0050","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bbalip.2022.159182_bb0055","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.106.138347","article-title":"Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL","volume":"27","author":"Yvan-Charvet","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.bbalip.2022.159182_bb0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2011.07.013","article-title":"The HDL proteome in acute coronary syndromes shifts to an inflammatory profile","volume":"1821","author":"Alwaili","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2022.159182_bb0065","article-title":"The HDL proteome watch: compilation of studies leads to new insights on HDL function","volume":"1867","author":"Davidson","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol.Lipids"},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0070","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/ATVBAHA.109.186031","article-title":"Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function","volume":"29","author":"Davidson","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.bbalip.2022.159182_bb0075","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/ATVBAHA.118.311607","article-title":"Distinct proteomic signatures in 16 HDL (High-Density Lipoprotein) subspecies","volume":"38","author":"Furtado","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.bbalip.2022.159182_bb0080","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1021\/pr100520x","article-title":"Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography","volume":"9","author":"Gordon","year":"2010","journal-title":"J. Proteome Res."},{"issue":"11","key":"10.1016\/j.bbalip.2022.159182_bb0085","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1074\/mcp.M113.028134","article-title":"Multi-dimensional co-separation analysis reveals protein-protein interactions defining plasma lipoprotein subspecies","volume":"12","author":"Gordon","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"issue":"10","key":"10.1016\/j.bbalip.2022.159182_bb0090","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/pmic.200401233","article-title":"Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins","volume":"5","author":"Heller","year":"2005","journal-title":"Proteomics"},{"issue":"9","key":"10.1016\/j.bbalip.2022.159182_bb0095","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.bbalip.2022.159182_bb0100","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.bbalip.2022.159182_bb0105","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bbrc.2005.12.098","article-title":"Diverse range of small peptides associated with high-density lipoprotein","volume":"340","author":"Hortin","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bbalip.2022.159182_bb0110","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/pmic.200401010","article-title":"Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry","volume":"5","author":"Karlsson","year":"2005","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/j.bbalip.2022.159182_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034107","article-title":"HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach","volume":"7","author":"Mange","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbalip.2022.159182_bb0120","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/pmic.200500191","article-title":"Proteomic analysis of high-density lipoprotein","volume":"6","author":"Rezaee","year":"2006","journal-title":"Proteomics"},{"issue":"8","key":"10.1016\/j.bbalip.2022.159182_bb0125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","article-title":"Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling","volume":"127","author":"Riwanto","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bbalip.2022.159182_bb0130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbalip.2012.12.015","article-title":"Distinct composition of human fetal HDL attenuates its anti-oxidative capacity","volume":"1831","author":"Sreckovic","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bbalip.2022.159182_bb0135","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0140","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.bbalip.2022.159182_bb0145","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum amyloid a in uremic HDL promotes inflammation","volume":"23","author":"Weichhart","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bbalip.2022.159182_bb0150","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.R039297","article-title":"Cardioprotective functions of HDLs","volume":"55","author":"Rye","year":"2014","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.bbalip.2022.159182_bb0155","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1161\/ATVBAHA.120.314609","article-title":"Protein-defined subspecies of HDLs (High-Density Lipoproteins) and differential risk of coronary heart disease in 4 prospective studies","volume":"40","author":"Sacks","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bbalip.2022.159182_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131491","article-title":"Structure-function relationships of HDL in diabetes and coronary heart disease","volume":"5","author":"Cardner","year":"2020","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.bbalip.2022.159182_bb0165","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbalip.2015.05.007","article-title":"Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A","volume":"1851","author":"Rached","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbalip.2022.159182_bb0170","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.atherosclerosis.2015.05.037","article-title":"Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL","volume":"241","author":"Sutter","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2\u20133","key":"10.1016\/j.bbalip.2022.159182_bb0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0163-7827(91)90008-S","article-title":"Apolipoprotein composition as the basis for classifying plasma lipoproteins.Characterization of ApoA- and ApoB-containing lipoprotein families","volume":"30","author":"Alaupovic","year":"1991","journal-title":"Prog. Lipid Res."},{"issue":"12","key":"10.1016\/j.bbalip.2022.159182_bb0180","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.bbalip.2022.159182_bb0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCRESAHA.114.300632","article-title":"Regulation of high-density lipoprotein metabolism","volume":"114","author":"Rye","year":"2014","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.bbalip.2022.159182_bb0190","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/CIRCULATIONAHA.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women","volume":"119","author":"Mora","year":"2009","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.bbalip.2022.159182_bb0195","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/CIRCULATIONAHA.111.073684","article-title":"Lipids and lipoproteins and risk of different vascular events in the MRC\/BHF Heart Protection Study","volume":"125","author":"Parish","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bbalip.2022.159182_bb0200","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1194\/jlr.R035725","article-title":"Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond","volume":"54","author":"Shah","year":"2013","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.bbalip.2022.159182_bb0205","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1194\/jlr.D061432","article-title":"Multiple apolipoprotein kinetics measured in human HDL by high-resolution\/accurate mass parallel reaction monitoring","volume":"57","author":"Singh","year":"2016","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11883-021-00925-4","article-title":"The difference between high density lipoprotein subfractions and subspecies: an evolving model in cardiovascular disease and diabetes","volume":"23","author":"Davidson","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"issue":"10","key":"10.1016\/j.bbalip.2022.159182_bb0215","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1194\/jlr.M042333","article-title":"Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease","volume":"55","author":"Talayero","year":"2014","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0220","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1194\/jlr.P073288","article-title":"Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III","volume":"58","author":"Koch","year":"2017","journal-title":"J. Lipid Res."},{"issue":"13","key":"10.1016\/j.bbalip.2022.159182_bb0225","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCULATIONAHA.117.031276","article-title":"High-density lipoprotein subspecies defined by presence of apolipoprotein C-III and incident coronary heart disease in four cohorts","volume":"137","author":"Jensen","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bbalip.2022.159182_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.111.000232","article-title":"Apolipoprotein C-III as a potential modulator of the association between HDL-cholesterol and incident coronary heart disease","volume":"1","author":"Jensen","year":"2012","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.bbalip.2022.159182_bb0235","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98045","article-title":"Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk","volume":"3","author":"Morton","year":"2018","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.bbalip.2022.159182_bb0240","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/01.ATV.17.4.715","article-title":"The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial","volume":"17","author":"Alaupovic","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"16","key":"10.1016\/j.bbalip.2022.159182_bb0245","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2022.159182_bb0250","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2017.12.029","article-title":"High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals","volume":"269","author":"Yamamoto","year":"2018","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0255","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007824","article-title":"High-density lipoprotein subspecies defined by apolipoprotein C-III and subclinical atherosclerosis measures: MESA (The Multi-Ethnic Study of Atherosclerosis)","volume":"7","author":"Aroner","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.bbalip.2022.159182_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11892-008-0010-5","article-title":"Why is HDL functionally deficient in type 2 diabetes?","volume":"8","author":"Kontush","year":"2008","journal-title":"Curr. Diab. Rep."},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0265","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1210\/clinem\/dgab075","article-title":"HDL particle subspecies and their association with incident type 2 diabetes: the PREVEND study","volume":"106","author":"Sokooti","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0270","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/aje\/kwx143","article-title":"Apolipoprotein C-III and high-density lipoprotein subspecies defined by apolipoprotein C-III in relation to diabetes risk","volume":"186","author":"Aroner","year":"2017","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0275","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00125-019-4847-8","article-title":"Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the multi-ethnic study of atherosclerosis","volume":"62","author":"Aroner","year":"2019","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.bbalip.2022.159182_bb0280","doi-asserted-by":"crossref","first-page":"e2928","DOI":"10.1210\/clinem\/dgab234","article-title":"HDL containing apolipoprotein C-III is associated with insulin sensitivity: a multicenter cohort study","volume":"106","author":"Yamamoto","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159182_bb0285","article-title":"Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer\u2019s disease","author":"Horgusluoglu","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.bbalip.2022.159182_bb0290","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jalz.2017.11.012","article-title":"Circulating metabolites and general cognitive ability and dementia: evidence from 11 cohort studies","volume":"14","author":"van der Lee","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbalip.2022.159182_bb0295","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1161\/STROKEAHA.121.034299","article-title":"HDL (High-Density Lipoprotein) subspecies, prevalent covert brain infarcts, and incident overt ischemic stroke: cardiovascular health study","volume":"53","author":"Koch","year":"2021","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.bbalip.2022.159182_bb0300","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MOL.0000000000000257","article-title":"HDL-cholesterol and apolipoproteins in relation to dementia","volume":"27","author":"Koch","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"issue":"12","key":"10.1016\/j.bbalip.2022.159182_bb0305","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bbalip.2022.159182_bb0310","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bbalip.2022.159182_bb0315","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/JMN:17:2:147","article-title":"Role of apoe\/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy","volume":"17","author":"Holtzman","year":"2001","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.bbalip.2022.159182_bb0320","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1750-3639.2005.tb00103.x","article-title":"Neurovascular pathways and Alzheimer amyloid beta-peptide","volume":"15","author":"Zlokovic","year":"2005","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.bbalip.2022.159182_bb0325","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.bbalip.2022.159182_bb0330","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/(SICI)1097-4547(19980301)51:5<658::AID-JNR13>3.0.CO;2-Z","article-title":"Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways","volume":"51","author":"Wang","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbalip.2022.159182_bb0335","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.dadm.2017.01.007","article-title":"Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma","volume":"6","author":"Koch","year":"2017","journal-title":"Alzheimers Dement. (Amst.)"},{"issue":"3","key":"10.1016\/j.bbalip.2022.159182_bb0340","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3233\/JAD-140111","article-title":"Apolipoprotein C-III is an amyloid-beta-binding protein and an early marker for Alzheimer's disease","volume":"41","author":"Shih","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.bbalip.2022.159182_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040113","article-title":"Lipoprotein genotype and conserved pathway for exceptional longevity in humans","volume":"4","author":"Atzmon","year":"2006","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.bbalip.2022.159182_bb0350","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.9250","article-title":"Association of Apolipoprotein E in lipoprotein subspecies with risk of dementia","volume":"3","author":"Koch","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.bbalip.2022.159182_bb0355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MOL.0000000000000383","article-title":"Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease","volume":"28","author":"Liao","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2022.159182_bb0360","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.dadm.2018.07.001","article-title":"Apolipoproteins and Alzheimer's pathophysiology","volume":"10","author":"Koch","year":"2018","journal-title":"Alzheimers Dement. (Amst.)"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198122000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198122000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:13:24Z","timestamp":1761387204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198122000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1388198122000725"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2022.159182","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein-based HDL subspecies: Rationale and association with cardiovascular disease, diabetes, stroke, and dementia","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2022.159182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"159182"}}